Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd cash flow quality index. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Quality Index of 2.18x as of September 2025. Operating cash flow of CN¥1.73 Billion exceeds net income of CN¥793.91 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of Guangzhou Baiyunshan Pharmaceutical Hold to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Cash flow quality index of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. Historical Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600332 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Quality Index by Year (2000–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd cash flow quality index by year from 2000 to 2025. Year-by-year earnings quality comparison for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For the full cash flow conversion analysis, see Guangzhou Baiyunshan Pharmaceutical Hold (600332) cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥260.23 Million | CN¥2.98 Billion | ▼ -92.4% |
| 2024 | 1.15x | CN¥3.44 Billion | CN¥3.00 Billion | ▲ +19.1% |
| 2023 | 0.96x | CN¥4.10 Billion | CN¥4.26 Billion | ▼ -41.5% |
| 2022 | 1.65x | CN¥7.00 Billion | CN¥4.25 Billion | ▲ +15.1% |
| 2021 | 1.43x | CN¥5.67 Billion | CN¥3.97 Billion | ▲ +655.2% |
| 2020 | 0.19x | CN¥585.19 Million | CN¥3.09 Billion | ▼ -87.0% |
| 2019 | 1.46x | CN¥5.02 Billion | CN¥3.44 Billion | ▼ -1.1% |
| 2018 | 1.48x | CN¥5.22 Billion | CN¥3.53 Billion | ▲ +70.6% |
| 2017 | 0.87x | CN¥1.83 Billion | CN¥2.12 Billion | ▼ -44.8% |
| 2016 | 1.57x | CN¥2.44 Billion | CN¥1.56 Billion | ▲ +8.7% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | ▼ -0.8% |
| 2014 | 1.45x | CN¥1.76 Billion | CN¥1.21 Billion | ▲ +9.4% |
| 2013 | 1.33x | CN¥1.34 Billion | CN¥1.01 Billion | ▲ +7.2% |
| 2012 | 1.24x | CN¥506.53 Million | CN¥408.33 Million | ▲ +306.7% |
| 2011 | -0.60x | CN¥-180.05 Million | CN¥300.00 Million | ▼ -324.8% |
| 2010 | 0.27x | CN¥73.17 Million | CN¥274.03 Million | ▼ -87.3% |
| 2009 | 2.10x | CN¥439.39 Million | CN¥208.77 Million | ▲ +5830.0% |
| 2008 | 0.04x | CN¥6.10 Million | CN¥171.96 Million | ▼ -96.7% |
| 2007 | 1.09x | CN¥375.74 Million | CN¥344.66 Million | ▲ +571.7% |
| 2006 | 0.16x | CN¥38.88 Million | CN¥239.54 Million | ▼ -78.5% |
| 2005 | 0.75x | CN¥146.32 Million | CN¥194.13 Million | ▼ -75.9% |
| 2004 | 3.13x | CN¥200.54 Million | CN¥64.07 Million | ▲ +6989.5% |
| 2003 | -0.05x | CN¥-6.83 Million | CN¥150.35 Million | ▼ -104.7% |
| 2002 | 0.97x | CN¥169.01 Million | CN¥174.38 Million | ▲ +8.5% |
| 2001 | 0.89x | CN¥140.15 Million | CN¥156.93 Million | ▼ -54.5% |
| 2000 | 1.96x | CN¥286.95 Million | CN¥146.23 Million | — |